Use of cannabinoids in the treatment of degenerative skeletal muscle diseases
US-2017304217-A1 · Oct 26, 2017 · US
Gw Pharma Ltd was listed as an assignee on 20 patent publications in 2017.
| Metric | Value |
|---|---|
| Company | Gw Pharma Ltd |
| Year | 2017 |
| Patents | 20 |
Representative publications for Gw Pharma Ltd in 2017.
US-2017304217-A1 · Oct 26, 2017 · US
US-2017290869-A1 · Oct 12, 2017 · US
US-2017273913-A1 · Sep 28, 2017 · US
US-2017266126-A1 · Sep 21, 2017 · US
US-2017246121-A1 · Aug 31, 2017 · US
Most common classification codes for Gw Pharma Ltd in 2017.
| CPC | Patents |
|---|---|
| A61K31/658 | 20 |
| A61K31/05 | 17 |
| A61K36/185 | 17 |
| A61K36/3482 | 14 |
| A61K45/06 | 13 |
Navigate to parent entity pages.